Taltz (ixekizumab) - Eli Lilly, Japan Tobacco
Bimzelx (bimekizumab) - UCB
CJM112 - Novartis
Humira (adalimumab) - AbbVie
Cosentyx (secukinumab) - Novartis
izokibep (ABY-035) - Affibody, ACELYRIN
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
Siliq (brodalumab) - Bausch Health, LEO Pharma, Kyowa Kirin
http://www.ncbi.nlm.nih.gov/pubmed/37896210
 
Andrea Chiricozzi; Dalma Malvaso; Flaminia Antonelli; Giulia Coscarella; Ketty Peris; Laura Calabrese; Pietro Rubegni
 
Oct 28, 2023
 
Prev Next